Literature DB >> 22729911

Promoter hypermethylation of p73 and p53 genes in cervical cancer patients among north Indian population.

Abhimanyu Kumar Jha1, Mohsen Nikbakht, Veena Jain, Alka Sehgal, Neena Capalash, Jagdeep Kaur.   

Abstract

Hypermethylation of CpG islands leads to transcriptional silencing and it is the predominant mechanism of tumor suppressor gene inactivation in many tumors. Methylation-specific polymerase chain reaction was performed to analyse the methylation status of the promoter region of the tumor suppressor genes. Hypermethylation of the 5' CpG island of the p21 ( CIP1 ), p27 ( KIP1 ), p57 ( KIP2 ), p53, p73 and RB 1 gene promoter were found in 8.8, 8.8, 11.2, 12, 25.6 and 4.8 % of 125 cervical cancer samples from north Indian population, respectively. Methylation of p73 was significantly (P < 0.001) associated with the cervical cancer cases in comparison to controls. Significant correlation was also observed between the methylation of p73 gene and increase in the risk of cervical cancer among passive smokers. Promoter hypermethylation of p53 gene was also observed to be significant among oral contraceptive users and cervical cancer patients having age at first sexual intercourse <20 years whereas hypermethylation of other genes was not found to be significant in the present study. This is the first report showing significant hypermethylation of p73 and p53 genes among cervical cancer patients in north Indian population. This is also the first report on significant p53 hypermethylation in cervical cancer in any population. Our findings did not show any correlation between promoter methylation of p73 and the other genes under study with clinicopathological parameters, including human papillomavirus infection and stage of the disease. The frequency of aberrant methylation of p73 and p53 gene promoter was unchanged according to the age of patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22729911     DOI: 10.1007/s11033-012-1787-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  59 in total

1.  Lack of p21(CIP1) DNA methylation in acute lymphocytic leukemia.

Authors:  LanLan Shen; Yutaka Kondo; Jean-Pierre Issa; Guillermo Garcia-Manero
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

2.  Retinoblastoma: a prototypic hereditary neoplasm.

Authors:  A G Knudson
Journal:  Semin Oncol       Date:  1978-03       Impact factor: 4.929

3.  Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.

Authors:  M Nakamura; T Sakaki; H Hashimoto; H Nakase; E Ishida; K Shimada; N Konishi
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

4.  Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells.

Authors:  I Bae; S Fan; K Bhatia; K W Kohn; A J Fornace; P M O'Connor
Journal:  Cancer Res       Date:  1995-06-01       Impact factor: 12.701

5.  Tumor suppression by p21WAF1.

Authors:  Y Q Chen; S C Cipriano; J M Arenkiel; F R Miller
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

6.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

7.  WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.

Authors:  W S el-Deiry; J W Harper; P M O'Connor; V E Velculescu; C E Canman; J Jackman; J A Pietenpol; M Burrell; D E Hill; Y Wang
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

Review 8.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

9.  Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer.

Authors:  Kianoosh Malekzadeh; Ranbir Chander Sobti; Mohsen Nikbakht; Mohammad Shekari; Seyed Ali Hosseini; Dormohammad Kordi Tamandani; S K Singh
Journal:  Cancer Invest       Date:  2009-01       Impact factor: 2.176

Review 10.  p73: Friend or foe in tumorigenesis.

Authors:  Gerry Melino; Vincenzo De Laurenzi; Karen H Vousden
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

View more
  10 in total

1.  TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.

Authors:  Jing Lai; Fang Yang; Wenwen Zhang; Yanru Wang; Jing Xu; Wei Song; Guichun Huang; Jun Gu; Xiaoxiang Guan
Journal:  Mol Cells       Date:  2014-08-18       Impact factor: 5.034

2.  Methylation of Breast Cancer Predisposition Genes in Early-Onset Breast Cancer: Australian Breast Cancer Family Registry.

Authors:  Cameron M Scott; JiHoon Eric Joo; Neil O'Callaghan; Daniel D Buchanan; Mark Clendenning; Graham G Giles; John L Hopper; Ee Ming Wong; Melissa C Southey
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

3.  Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer.

Authors:  Prakriti Sen; Pooja Ganguly; Niladri Ganguly
Journal:  Oncol Lett       Date:  2017-10-30       Impact factor: 2.967

4.  Association of P73 polymorphisms with susceptibilities of cervical carcinoma: a meta-analysis.

Authors:  Xianghua Liang; Bingxiang Chen; Jianxin Zhong
Journal:  Oncotarget       Date:  2017-05-24

5.  PRIMA-1 targets the vulnerability of multiple myeloma of deregulated protein homeostasis through the perturbation of ER stress via p73 demethylation.

Authors:  Phaik Ju Teoh; Chonglei Bi; Chirackal Sintosebastian; Liang Seah Tay; Rafael Fonseca; Wee Joo Chng
Journal:  Oncotarget       Date:  2016-09-20

6.  Bioinformatics analysis of methylation in cervical adenocarcinoma in Xinjiang, China.

Authors:  Min Yuan; Jianlin Yuan; Lipa Mei; Guzhalinuer Abulizi
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

Review 7.  Overcome cancer drug resistance by targeting epigenetic modifications of centrosome.

Authors:  Zan-Hui Jia; Xing-Gang Wang; Hong Zhang
Journal:  Cancer Drug Resist       Date:  2019-06-19

8.  Gene Promoter-Methylation Signature as Biomarker to Predict Cisplatin-Radiotherapy Sensitivity in Locally Advanced Cervical Cancer.

Authors:  Carlos Contreras-Romero; Eloy-Andrés Pérez-Yépez; Antonio Daniel Martinez-Gutierrez; Alma Campos-Parra; Alejandro Zentella-Dehesa; Nadia Jacobo-Herrera; César López-Camarillo; Guillermo Corredor-Alonso; Jaime Martínez-Coronel; Mauricio Rodríguez-Dorantes; David Cantu de León; Carlos Pérez-Plasencia
Journal:  Front Oncol       Date:  2022-03-03       Impact factor: 6.244

9.  Repeated PM2.5 exposure inhibits BEAS-2B cell P53 expression through ROS-Akt-DNMT3B pathway-mediated promoter hypermethylation.

Authors:  Wei Zhou; Dongdong Tian; Jun He; Yimei Wang; Lijun Zhang; Lan Cui; Li Jia; Li Zhang; Lizhong Li; Yulei Shu; Shouzhong Yu; Jun Zhao; Xiaoyan Yuan; Shuangqing Peng
Journal:  Oncotarget       Date:  2016-04-12

10.  Anti-Proliferative Effect of Statins Is Mediated by DNMT1 Inhibition and p21 Expression in OSCC Cells.

Authors:  Rachmad Anres Dongoran; Kai-Hung Wang; Tsung-Jen Lin; Ta-Chun Yuan; Chin-Hung Liu
Journal:  Cancers (Basel)       Date:  2020-07-28       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.